539206
GVBL
Start SIP
Invest Now
Start SIP in GVBL
Performance
- Low
- ₹22
- High
- ₹24
- 52 Week Low
- ₹21
- 52 Week High
- ₹94
- Open Price₹22
- Previous Close₹24
- Volume3,170
Investment Returns
- Over 1 Month -22.31%
- Over 3 Month -33.83%
- Over 6 Month -50.99%
- Over 1 Year -71.16%
Smart Investing Starts Here Start SIP with Genomic Valley Biotech for Steady Growth!
Genomic Valley Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 72.8
- PEG Ratio
- -1.2
- Market Cap Cr
- 7
- P/B Ratio
- 1.9
- Average True Range
- 2.53
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -1.68
- RSI
- 42.71
- MFI
- 19.74
Genomic Valley Biotech Financials
Genomic Valley Biotech Technicals
EMA & SMA
Current Price
₹23.82
+
0.03
(0.13%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹24.89
- 50 Day
- ₹28.13
- 100 Day
- ₹33.40
- 200 Day
- ₹41.33
Resistance and Support
23.24
- R3 26.67
- R2 25.34
- R1 24.57
- S1 22.47
- S2 21.14
- S3 20.37
Genomic Valley Biotech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-10-15 | Quarterly Results | |
| 2025-08-07 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-14 | Quarterly Results | |
| 2024-12-06 | Others | Inter alia - To consider and Approve (1) The Directors Report for the Year 2023-24. (2) 30th AGM of the Company and Other Business Matters. |
Genomic Valley Biotech F&O
About Genomic Valley Biotech
- NSE Symbol
- GVBL
- BSE Symbol
- 539206
- Managing Director
- Mr. Yogesh Agrawal
- ISIN
- INE574D01010
Similar Stocks to Genomic Valley Biotech
Genomic Valley Biotech FAQs
Genomic Valley Biotech share price is ₹23 As on 30 December, 2025 | 02:50
The Market Cap of Genomic Valley Biotech is ₹7.3 Cr As on 30 December, 2025 | 02:50
The P/E ratio of Genomic Valley Biotech is 72.8 As on 30 December, 2025 | 02:50
The PB ratio of Genomic Valley Biotech is 1.9 As on 30 December, 2025 | 02:50
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.